Complete Health Indicator Report of Incidence of Prostate Cancer
Definition
Incidence rate of invasive prostate cancer for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.Numerator
Number of new cases of prostate cancer among a defined population in a specified time interval.Denominator
Defined population in a specified time interval.Why Is This Important?
During 2018, 7,550 men in New Jersey were diagnosed with cancer of the prostate. Prostate cancer is the most frequently diagnosed cancer among men in NJ and the US, excluding basal and squamous cell carcinomas of the skin. Prostate cancer occurs more frequently as men age, with most cases occurring after age 50.How Are We Doing?
Prostate cancer incidence rates have decreased overall after 1992. This trend is thought to be due to changes in prostate cancer screening practices. The lifetime risk of developing prostate cancer is 1 in 9 for men.What Is Being Done?
A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]Available Services
The New Jersey Department of Health (NJDOH) has many programs and partnerships related to cancer data and information, cancer resources and cancer prevention. Cancer Epidemiology Services: [https://nj.gov/health/ces/] Interactive New Jersey cancer incidence and mortality data, as well as numerous publications, are available through the NJDOH website for cancer statistics and mapping. [https://www.nj.gov/health/ces/cancer-researchers/cancer-data/index.shtml] Office of Cancer Control and Prevention: [https://www.nj.gov/health/ces/public/resources/occp.shtml] NJ Cancer Education and Early Detection (NJCEED): [https://www.nj.gov/health/ces/public/resources/njceed.shtml] NJ Commission on Cancer Research: [https://www.nj.gov/health/ces/cancer-researchers/njccr.shtml]Related Indicators
Related Health Status Outcomes Indicators:
Data Tables
NJ Age-Adjusted Invasive Prostate Cancer Incidence, Males, by Year, 1990 - 2018
Year | Age-Adjusted Rate per 100,000 | Lower Limit | Upper Limit | Numer- ator | ||
---|---|---|---|---|---|---|
Record Count: 29 | ||||||
1990 | 148.4 | 143.9 | 153.0 | 4,548 | ||
1991 | 191.8 | 186.9 | 196.9 | 6,128 | ||
1992 | 247.2 | 241.6 | 252.8 | 8,174 | ||
1993 | 221.1 | 215.9 | 226.3 | 7,448 | ||
1994 | 192.2 | 187.5 | 197.0 | 6,609 | ||
1995 | 189.6 | 185.0 | 194.3 | 6,652 | ||
1996 | 194.6 | 189.9 | 199.3 | 6,888 | ||
1997 | 204.2 | 199.5 | 209.0 | 7,316 | ||
1998 | 188.2 | 183.7 | 192.8 | 6,852 | ||
1999 | 197.6 | 193.1 | 202.2 | 7,297 | ||
2000 | 207.5 | 202.9 | 212.2 | 7,778 | ||
2001 | 217.0 | 212.4 | 221.8 | 8,242 | ||
2002 | 218.3 | 213.7 | 223.1 | 8,435 | ||
2003 | 176.6 | 172.4 | 180.8 | 6,924 | ||
2004 | 161.0 | 157.1 | 165.1 | 6,386 | ||
2005 | 165.2 | 161.2 | 169.3 | 6,635 | ||
2006 | 183.8 | 179.6 | 188.1 | 7,579 | ||
2007 | 188.9 | 184.7 | 193.1 | 7,946 | ||
2008 | 171.9 | 168.0 | 175.9 | 7,441 | ||
2009 | 169.8 | 165.9 | 173.7 | 7,512 | ||
2010 | 158.2 | 154.5 | 162.0 | 7,166 | ||
2011 | 169.4 | 165.6 | 173.3 | 7,829 | ||
2012 | 136.9 | 133.5 | 140.3 | 6,502 | ||
2013 | 129.6 | 126.3 | 132.9 | 6,359 | ||
2014 | 121.3 | 118.2 | 124.4 | 6,059 | ||
2015 | 130.6 | 127.5 | 133.9 | 6,693 | ||
2016 | 138.7 | 135.4 | 142.0 | 7,246 | ||
2017 | 141.5 | 138.3 | 144.8 | 7,582 | ||
2018 | 139.1 | 135.9 | 142.3 | 7,550 |
Data Notes
Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified.Data Sources
- NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]
- NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]
NJ Age-Adjusted Invasive Prostate Cancer Incidence by County, Males, 2014-2018
County | Age-Adjusted Rate per 100,000 Males | Lower Limit | Upper Limit | Numer- ator | ||
---|---|---|---|---|---|---|
Record Count: 22 | ||||||
Atlantic | 121.8 | 114.5 | 129.6 | 1,072 | ||
Bergen | 131.1 | 126.9 | 135.5 | 3,785 | ||
Burlington | 154.2 | 147.6 | 161.1 | 2,153 | ||
Camden | 147.9 | 141.6 | 154.5 | 2,141 | ||
Cape May | 153.4 | 141.3 | 166.6 | 622 | ||
Cumberland | 133.4 | 122.4 | 145.1 | 565 | ||
Essex | 157.5 | 151.8 | 163.3 | 3,118 | ||
Gloucester | 142.3 | 134.2 | 150.8 | 1,233 | ||
Hudson | 111.4 | 105.8 | 117.1 | 1,613 | ||
Hunterdon | 118.1 | 107.8 | 129.3 | 527 | ||
Mercer | 152.8 | 145.1 | 160.8 | 1,568 | ||
Middlesex | 126.5 | 121.8 | 131.3 | 2,899 | ||
Monmouth | 141.5 | 136.2 | 147.0 | 2,854 | ||
Morris | 130.1 | 124.3 | 136.0 | 2,033 | ||
Ocean | 118.6 | 113.9 | 123.4 | 2,518 | ||
Passaic | 138.0 | 131.6 | 144.6 | 1,863 | ||
Salem | 131.9 | 116.4 | 149.0 | 277 | ||
Somerset | 126.1 | 118.9 | 133.6 | 1,218 | ||
Sussex | 117.6 | 107.7 | 128.2 | 584 | ||
Union | 138.6 | 132.5 | 145.0 | 2,061 | ||
Warren | 115.1 | 104.1 | 127.1 | 420 | ||
New Jersey | 134.5 | 133.0 | 135.9 | 35,130 |
Data Notes
Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified.Data Sources
- NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]
- NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]
References and Community Resources
Additional NJ prostate cancer information and statistics are available at [https://www.nj.gov/health/ces/documents/briefs/prostate_inc_mort_byrace_eth18.pdf]
Page Content Updated On 10/04/2021,
Published on 12/03/2021